INS and metabolic dysfunction-associated steatotic liver disease: Furthermore, it restored insulin sensitivity in insulin-resistant mice as well as mice fed an HFHFr diet; these results strongly indicate that ATRA may serve as a viable treatment option for NAFLD-associated insulin resistance [275].